IRIDEX CORP Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
IRIDEX CORP (IRIX) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $486.00 thousand as of 2026-01-03, per its 10-K filed 2026-04-02.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-04-02
- 2026-01-03: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $486.00K.
- 2024-12-28: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $574.00K.
- 2023-12-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $725.00K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $717.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2026-01-03 | $486.00K 10-K · filed 2026-04-02 |
| 2024-12-28 | $574.00K 10-K · filed 2026-04-02 |
| 2023-12-30 | $725.00K 10-K · filed 2025-03-27 |
| 2022-12-31 | $717.00K 10-K · filed 2024-03-29 |
| 2022-01-01 | $574.00K 10-K · filed 2023-03-09 |
| 2021-01-02 | $658.00K 10-K · filed 2022-03-15 |
| 2019-12-28 | $657.00K 10-K · filed 2021-03-23 |
| 2018-12-29 | $797.00K 10-K · filed 2020-03-13 |
| 2017-12-30 | $528.00K 10-K · filed 2019-03-29 |
| 2016-12-31 | $972.00K 10-K · filed 2018-03-14 |
| 2016-01-02 | $613.00K 10-K · filed 2017-03-15 |
| 2015-01-03 | $676.00K 10-K · filed 2016-03-31 |
| 2013-12-28 | $696.00K 10-K · filed 2015-04-02 |
| 2012-12-29 | $753.00K 10-K · filed 2014-03-27 |
| 2011-12-31 | $789.00K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |